SummaryCornification and epidermal barrier defects are associated with a number of clinically diverse skin disorders. However, a suitable in vitro model for studying normal barrier function and barrier defects is still lacking. Here, we demonstrate the generation of human epidermal equivalents (HEEs) from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). HEEs are structurally similar to native epidermis, with a functional permeability barrier. We exposed a pure population of hESC/iPSC-derived keratinocytes, whose transcriptome corresponds to the gene signature of normal primary human keratinocytes (NHKs), to a sequential high-to-low humidity environment in an air/liquid interface culture. The resulting HEEs had ...
Recreating the structure of human tissues in the laboratory is valuable for fundamental research, te...
The skin barrier is an important shield regulating the outside-in as well as inside-out penetration ...
Nowadays, human skin constructs (HSCs) are required for biomaterials, pharmaceuticals and cosmetics ...
Cornification and epidermal barrier defects are associated with a number of clinically diverse skin ...
SummaryCornification and epidermal barrier defects are associated with a number of clinically divers...
Cornification and epidermal barrier defects are associated with a number of clinically diverse skin ...
Multilayered human keratinocyte cultures increasingly are used to model human epidermis. Until now, ...
The three-dimensional culturing of human keratinocytes at the air-liquid interface yields a fully st...
A three-dimensional human epidermis model reconstructed from neonatal primary keratinocytes is prese...
Background: Cell therapy for large burns has successfully made use of autologous epidermis reconstru...
A three-dimensional human epidermis model reconstructed from neonatal primary keratinocytes is prese...
<div><p>The current utility of 3D skin equivalents is limited by the fact that existing models fail ...
Human embryonic stem (hES) cells are an attractive source of cellular material for scientific, diagn...
The current utility of 3D skin equivalents is limited by the fact that existing models fail to recap...
Contains fulltext : 177146.pdf (publisher's version ) (Open Access)The strong soci...
Recreating the structure of human tissues in the laboratory is valuable for fundamental research, te...
The skin barrier is an important shield regulating the outside-in as well as inside-out penetration ...
Nowadays, human skin constructs (HSCs) are required for biomaterials, pharmaceuticals and cosmetics ...
Cornification and epidermal barrier defects are associated with a number of clinically diverse skin ...
SummaryCornification and epidermal barrier defects are associated with a number of clinically divers...
Cornification and epidermal barrier defects are associated with a number of clinically diverse skin ...
Multilayered human keratinocyte cultures increasingly are used to model human epidermis. Until now, ...
The three-dimensional culturing of human keratinocytes at the air-liquid interface yields a fully st...
A three-dimensional human epidermis model reconstructed from neonatal primary keratinocytes is prese...
Background: Cell therapy for large burns has successfully made use of autologous epidermis reconstru...
A three-dimensional human epidermis model reconstructed from neonatal primary keratinocytes is prese...
<div><p>The current utility of 3D skin equivalents is limited by the fact that existing models fail ...
Human embryonic stem (hES) cells are an attractive source of cellular material for scientific, diagn...
The current utility of 3D skin equivalents is limited by the fact that existing models fail to recap...
Contains fulltext : 177146.pdf (publisher's version ) (Open Access)The strong soci...
Recreating the structure of human tissues in the laboratory is valuable for fundamental research, te...
The skin barrier is an important shield regulating the outside-in as well as inside-out penetration ...
Nowadays, human skin constructs (HSCs) are required for biomaterials, pharmaceuticals and cosmetics ...